Bonesupport names new member to executive team to boost North American presence: 5 insights

Sweden-based Bonesupport appointed Patrick O'Donnell general manager and executive vice president of North American commercialization.

Here are five insights:

1. In his new role, Mr. O'Donnell will work with the company's partner, Zimmer Biomet, to expand sales of Bonesupport's Cerament Bone Void Filler.

2. Mr. O'Donnell will also be in charge of introducing Cerament G, a gentamicin eluting bone graft substitute, to the U.S. market, following trial outcomes.

3. Researchers will test Cerament G in the FORTIFY pre-market approval trial.

4. Prior to taking on this role, Mr. O'Donnell co-founded and served as CEO of ProteoThera, based in Cambridge, Mass.

5. Bonesupport offers injectable bioceramic bone graft substitutes to treat bone voids.